Pilot-scale production of therapeutically-active cannabinoids

在试验规模上从大麻中分离出少量具有治疗活性的大麻素将建立一个具有商业竞争力的澳大利亚工业，并在全球市场上占据上级地位。该项目旨在从基因多样的大麻品系中选择优良克隆，以生产少量但具有治疗活性的大麻素，并开发一种可扩大规模用于商业生产的中试规模提取和分离程序。这将有助于农业生物技术部门的发展和澳大利亚农村地区熟练的多学科劳动力的增长，从而带来巨大的经济效益。这种新的放大程序有可能被工业采用，为澳大利亚制造业增加价值。

The Isolation of minor therapeutically-active cannabinoids from cannabis at pilot scale would establish a commercially competitive Australian industry and lead to a superior position in the global marketplace. This project aims to select elite clones from genetically diverse cannabis strains for yield of minor, but therapeutically-active, cannabinoids, and develop a pilot-scale extraction and separation procedure that can be scaled-up for commercial production. This would contribute to the growth of the agri-biotechnology sector and a skilled multidisciplinary workforce in rural Australia, thus providing significant economic benefit. The novel scale-up procedure has potential for industry adoption to add value to Australian manufacturing.